Literature DB >> 9152713

Dual diagnosis in elders discharged from a psychiatric hospital.

C E Blixen1, G J McDougall, L J Suen.   

Abstract

Recent evidence indicates persons 60 years and over experience significant alcohol and substance abuse problems. Since a combination of alcoholism and depression is likely to increase the relative rsk of suicide, it is important to examine the prevalence of dual diagnosis in older adults. The purpose of this study is to examine the prevalence and correlates of dual diagnosis in older psychiatric inpatient populations and compare our results with findings from studies of younger hospitalized dually diagnosed patients. A retrospective chart audit was performed on 101 elders who were discharged from three psychiatric hospitals. Clinical variables that were examined included length of hospital stay, psychiatric and medical diagnoses, medications and history of suicidal ideation or intent. The leading psychiatric disorder diagnosis for our sample of hospitalized psychiatric elders was depression. Over one-third (37.6%) had a substance abuse disorder in addition to a psychiatric disorder, and almost three-fourths (71%) of this 'dual diagnosis' group abused alcohol and 29% abused both alcohol and other substances. In addition, significantly more elders in the "dual diagnosis' group (17.7%) than in the group with only a mental disorder diagnosis (3.3%) made a suicide attempt prior to admission to the hospital. Because, affective disorders in conjunction with alcohol abuse are the most frequently found disorders in completed suicides, our findings have important relevance for the advocating of routine use of diagnostic assessment and screening for both substance abuse and mental disorders in this population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152713      PMCID: PMC6421078          DOI: 10.1002/(sici)1099-1166(199703)12:3<307::aid-gps475>3.0.co;2-6

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  8 in total

1.  The process and outcome of life review psychotherapy with depressed homebound older adults.

Authors:  G J McDougall; C E Buxen; L J Suen
Journal:  Nurs Res       Date:  1997 Sep-Oct       Impact factor: 2.381

2.  Sixteen-month evaluation of depressive symptomatology in older adults.

Authors:  Graham J McDougall; Stephanie Morgan; Phillip W Vaughan
Journal:  Arch Psychiatr Nurs       Date:  2012-02-01       Impact factor: 2.218

3.  Treatment of late-life depression complicated by alcohol dependence.

Authors:  David W Oslin
Journal:  Am J Geriatr Psychiatry       Date:  2005-06       Impact factor: 4.105

4.  Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders.

Authors:  Raj K Kalapatapu; Aimee Campbell; Efrat Aharonovich; Mei-Chen Hu; Frances R Levin; Edward V Nunes
Journal:  J Addict Med       Date:  2013 Jan-Feb       Impact factor: 3.702

5.  Course of late-life depression with alcoholism following combination therapy.

Authors:  Raman Gopalakrishnan; Jennifer Ross; Charles O'Brien; David Oslin
Journal:  J Stud Alcohol Drugs       Date:  2009-03       Impact factor: 2.582

6.  Alcohol use among older adults in the National Epidemiologic Survey on Alcohol and Related Conditions: a latent class analysis.

Authors:  Paul Sacco; Kathleen K Bucholz; Edward L Spitznagel
Journal:  J Stud Alcohol Drugs       Date:  2009-11       Impact factor: 2.582

7.  Suicide mortality among individuals receiving treatment for depression in the Veterans Affairs health system: associations with patient and treatment setting characteristics.

Authors:  Kara Zivin; H Myra Kim; John F McCarthy; Karen L Austin; Katherine J Hoggatt; Heather Walters; Marcia Valenstein
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

Review 8.  Late-life depression and alcoholism.

Authors:  Frederic C Blow; Alisha M Serras; Kristen Lawton Barry
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 8.081

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.